Dendrite Appoints Kathleen E. Donovan Chief Financial Officer.

Business Editors/Health & Medical Writers/High-Tech Writers

MORRISTOWN, N.J.--(BUSINESS WIRE)--March 10, 2003

Six-Year Company Executive To Continue Tradition of Providing Strong

Financial Leadership and Supporting Corporate Growth

Dendrite International, Inc. (NASDAQ: DRTE) today announced the immediate appointment of Kathleen E. Donovan as Chief Financial Officer.

Serving in a number of key executive positions since joining Dendrite in 1997, Ms. Donovan has been Dendrite's Acting Chief Financial Officer since November 2002. She has also previously served as Vice President and Treasurer, Chief Financial Officer of American Operations, Vice President and Corporate Controller, and Director of Financial Operations. During this time, Dendrite experienced a period of unprecedented growth, with corporate revenue climbing from $91 million in 1997 to nearly $226 million in 2002.

"Kathy has enjoyed a distinguished career at Dendrite, and her promotion to the CFO position will ensure strong and uninterrupted financial leadership within the company," said Dendrite Chairman and Chief Executive Officer John Bailye. "Her tenure here has been marked by significant corporate growth, and we look forward to continued steady progress and development under her financial guidance."

During her tenure at Dendrite, Ms. Donovan has been involved in all aspects of Dendrite's financial management. As CFO of American Operations, she helped to maximize revenue and profit for the company's largest division. Ms. Donovan has also been responsible for corporate accounting and SEC reporting; financial planning; investor relations, treasury, insurance, credit and collections; pricing; and merger and acquisition analysis.

"Dendrite's core strengths include an experienced executive team, solid base of leading clients, cutting-edge technology solutions, and world-class services for the global pharmaceutical industry," said Ms. Donovan. "I look forward to helping the company continue its momentum, while ensuring that we maintain the high level of financial responsibility that has been Dendrite's hallmark in the past."

* Prior to joining Dendrite, Ms. Donovan spent 14 years at Unisys Corporation--a $6 billion computer company providing hardware, software, information services, and maintenance worldwide--most recently as Director of Corporate Finance. Ms. Donovan holds a Bachelor of Science in Finance from Georgetown University.

About Dendrite

Dendrite develops and delivers solutions that increase value in sales, marketing, and clinical processes for life sciences clients. For more information, visit www.dendrite.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

The foregoing contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The statements may be identified by such forward-looking terminology as "expect," "believe," "may," "will," "intend," "plan," and similar statements or variations. All "outlook" information constitutes forward-looking statements. Such forward-looking statements are based on our current expectations, estimates, assumptions and projections and involve certain significant risks and uncertainties, including those which may result from our dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy sales and implementation cycles for our products, our fixed expenses in relation to fluctuating revenues and variations in customers' budget cycles; dependence on major customers; changes in demand for our products and services attributable to the current weakness in the economy; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; international operations; acquisitions; events which may affect the U.S. and world economies; our ability to manage our growth; the protection of our proprietary technology; our ability to compete in the Internet-related products and services market; the continued demand for Internet-related products and services; the ability of our third party vendors to respond to technological change; our ability to maintain our relationships with third-party vendors; the potential for hostilities in the Middle East and Asia and the resulting impact on our business and the business and needs of our customers; and catastrophic events which could negatively affect our information technology infrastructure. Other important factors that should be considered are included in the Company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The Company assumes no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or other changes affecting such forward-looking statements.